---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-26-000005"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T11:00:11.843020+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# USANA prelim FY2025 sales ~$925M (beat guidance); FY2026 guidance $925M-$1B

## Summary
- Preliminary FY2025 net sales of ~$925M, above prior guidance of ~$920M.
- FY2026 net sales guidance of $925M-$1.0B; core USANA nutritional seen at $720-765M (down from ~$777M).
- Hiya segment guided $140-155M (up from ~$132M); Rise Wellness $65-80M (up from ~$16M).
- FY2026 is a 52-week year (one week less than FY2025), impacting core business comparison.
- Rise Wellness margins expected at breakeven in FY2026 due to growth investments; working capital rising at both Hiya and Rise.

## SEC filing metadata
- accession: 0000896264-26-000005
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626426000005/0000896264-26-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626426000005/usna-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-26-000005
- JSON: https://secwatch.observer/filing/0000896264-26-000005.json
- Plain text: https://secwatch.observer/filing/0000896264-26-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.